PONS

Company profile

PONS company profile

Converting everyday ultrasound with AI to become the largest high-quality imaging data source on early-stage disease and injury assessment for preventive monitoring of chronic diseases and injury assessment in the field. PONS` device-agnostic, patented software and AI models to optimize ultrasound imaging quality, augment tissue contrast, and reduce signal noise while revealing anatomical features, structural delineations, and environmental context that remain undetectable with conventional ultrasound systems. PONS` patented technology can implement digital contrast without needing chemical contrast injected into the patients, revealing the surroundings at the earliest stages. Our proprietary deep learning algorithms quantitatively analyze tissue variations in morphological and spatial parameters—including tissue geometry, location, surrounding, and positional dynamics—to generate AI-powered risk assessment reports.